Structure

Physi-Chem Properties

Molecular Weight:  384.12
Volume:  377.986
LogP:  3.044
LogD:  2.632
LogS:  -4.325
# Rotatable Bonds:  3
TPSA:  105.45
# H-Bond Aceptor:  7
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.747
Synthetic Accessibility Score:  3.841
Fsp3:  0.286
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.729
MDCK Permeability:  1.5536232240265235e-05
Pgp-inhibitor:  0.055
Pgp-substrate:  0.008
Human Intestinal Absorption (HIA):  0.013
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.106

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.03
Plasma Protein Binding (PPB):  92.0634765625%
Volume Distribution (VD):  1.08
Pgp-substrate:  8.655123710632324%

ADMET: Metabolism

CYP1A2-inhibitor:  0.551
CYP1A2-substrate:  0.664
CYP2C19-inhibitor:  0.16
CYP2C19-substrate:  0.172
CYP2C9-inhibitor:  0.598
CYP2C9-substrate:  0.807
CYP2D6-inhibitor:  0.556
CYP2D6-substrate:  0.189
CYP3A4-inhibitor:  0.825
CYP3A4-substrate:  0.284

ADMET: Excretion

Clearance (CL):  14.059
Half-life (T1/2):  0.494

ADMET: Toxicity

hERG Blockers:  0.079
Human Hepatotoxicity (H-HT):  0.361
Drug-inuced Liver Injury (DILI):  0.867
AMES Toxicity:  0.108
Rat Oral Acute Toxicity:  0.887
Maximum Recommended Daily Dose:  0.917
Skin Sensitization:  0.902
Carcinogencity:  0.777
Eye Corrosion:  0.003
Eye Irritation:  0.033
Respiratory Toxicity:  0.934

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475784

Natural Product ID:  NPC475784
Common Name*:   (2S)-5,7-Dihydroxy-2'-(Hydroxymethyl)-8'-Methoxy-2'-Methyl-2,6'-Bichroman-4-One
IUPAC Name:   (2S)-5,7-dihydroxy-2-[2-(hydroxymethyl)-8-methoxy-2-methylchromen-6-yl]-2,3-dihydrochromen-4-one
Synonyms:  
Standard InCHIKey:  DNWBCRWFRVKNFW-BJQOMGFOSA-N
Standard InCHI:  InChI=1S/C21H20O7/c1-21(10-22)4-3-11-5-12(6-18(26-2)20(11)28-21)16-9-15(25)19-14(24)7-13(23)8-17(19)27-16/h3-8,16,22-24H,9-10H2,1-2H3/t16-,21?/m0/s1
SMILES:  CC1(C=CC2=C(O1)C(=CC(=C2)C3CC(=O)C4=C(C=C(C=C4O3)O)O)OC)CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL515537
PubChem CID:   25147600
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0003520] Pyranoflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota stem bark n.a. n.a. PMID[17489632]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. stem n.a. PMID[18484536]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota stem bark Mukono, Uganda 2005-JUN PMID[19008110]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19836230]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[20337486]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[21116437]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 = 17900.0 nM PMID[518879]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475784 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9934 High Similarity NPC474038
0.9868 High Similarity NPC192686
0.9868 High Similarity NPC284820
0.9868 High Similarity NPC119209
0.9868 High Similarity NPC473272
0.9868 High Similarity NPC118256
0.9805 High Similarity NPC472625
0.9804 High Similarity NPC26326
0.9804 High Similarity NPC472632
0.9803 High Similarity NPC473990
0.974 High Similarity NPC474033
0.974 High Similarity NPC474034
0.9739 High Similarity NPC174953
0.9737 High Similarity NPC472598
0.9737 High Similarity NPC27337
0.9737 High Similarity NPC474055
0.9677 High Similarity NPC186686
0.9675 High Similarity NPC472634
0.9675 High Similarity NPC471210
0.9673 High Similarity NPC117418
0.9673 High Similarity NPC53545
0.9671 High Similarity NPC35038
0.9671 High Similarity NPC195796
0.9671 High Similarity NPC278778
0.9671 High Similarity NPC291878
0.9613 High Similarity NPC472635
0.9613 High Similarity NPC474150
0.9613 High Similarity NPC474162
0.9613 High Similarity NPC476247
0.961 High Similarity NPC282009
0.961 High Similarity NPC287328
0.961 High Similarity NPC472624
0.961 High Similarity NPC472631
0.961 High Similarity NPC472630
0.9608 High Similarity NPC291508
0.9608 High Similarity NPC471209
0.9608 High Similarity NPC78071
0.9608 High Similarity NPC52889
0.9605 High Similarity NPC321779
0.9605 High Similarity NPC226025
0.9605 High Similarity NPC470327
0.9605 High Similarity NPC477503
0.9605 High Similarity NPC45849
0.9605 High Similarity NPC200761
0.9554 High Similarity NPC471213
0.9554 High Similarity NPC43319
0.9551 High Similarity NPC124038
0.9548 High Similarity NPC471499
0.9548 High Similarity NPC142252
0.9548 High Similarity NPC471211
0.9548 High Similarity NPC289771
0.9548 High Similarity NPC471212
0.9548 High Similarity NPC134783
0.9545 High Similarity NPC74178
0.9545 High Similarity NPC184755
0.9545 High Similarity NPC187792
0.9545 High Similarity NPC22192
0.9545 High Similarity NPC204879
0.9542 High Similarity NPC470328
0.9542 High Similarity NPC209614
0.9542 High Similarity NPC471985
0.9542 High Similarity NPC472626
0.9539 High Similarity NPC7989
0.9539 High Similarity NPC213896
0.9539 High Similarity NPC74924
0.9539 High Similarity NPC472583
0.9539 High Similarity NPC223701
0.9539 High Similarity NPC18727
0.9539 High Similarity NPC192083
0.9494 High Similarity NPC218226
0.949 High Similarity NPC293319
0.949 High Similarity NPC62261
0.9487 High Similarity NPC83922
0.9487 High Similarity NPC472448
0.9484 High Similarity NPC36217
0.9484 High Similarity NPC470326
0.9484 High Similarity NPC204290
0.9484 High Similarity NPC328102
0.9481 High Similarity NPC474681
0.9481 High Similarity NPC223787
0.9481 High Similarity NPC218313
0.9481 High Similarity NPC183851
0.9481 High Similarity NPC63454
0.9477 High Similarity NPC259710
0.9477 High Similarity NPC234255
0.9477 High Similarity NPC217706
0.9477 High Similarity NPC48579
0.9477 High Similarity NPC207809
0.9477 High Similarity NPC304207
0.9474 High Similarity NPC471982
0.9474 High Similarity NPC475790
0.9474 High Similarity NPC56232
0.9474 High Similarity NPC106976
0.9474 High Similarity NPC219582
0.9474 High Similarity NPC40033
0.9474 High Similarity NPC150123
0.9474 High Similarity NPC302950
0.9474 High Similarity NPC161881
0.9474 High Similarity NPC10807
0.9474 High Similarity NPC236637
0.9474 High Similarity NPC244583
0.947 High Similarity NPC338131
0.947 High Similarity NPC472633
0.9434 High Similarity NPC288813
0.9434 High Similarity NPC475212
0.943 High Similarity NPC119589
0.943 High Similarity NPC272502
0.943 High Similarity NPC120593
0.9423 High Similarity NPC165970
0.9423 High Similarity NPC158188
0.9423 High Similarity NPC198829
0.9423 High Similarity NPC167678
0.9423 High Similarity NPC113163
0.9423 High Similarity NPC66618
0.9423 High Similarity NPC305987
0.9423 High Similarity NPC84324
0.9423 High Similarity NPC288131
0.9423 High Similarity NPC29876
0.9419 High Similarity NPC95936
0.9419 High Similarity NPC172202
0.9419 High Similarity NPC284127
0.9419 High Similarity NPC250214
0.9419 High Similarity NPC476410
0.9416 High Similarity NPC208152
0.9416 High Similarity NPC133970
0.9416 High Similarity NPC326037
0.9416 High Similarity NPC6633
0.9416 High Similarity NPC320825
0.9416 High Similarity NPC282307
0.9416 High Similarity NPC13858
0.9416 High Similarity NPC170026
0.9416 High Similarity NPC5322
0.9416 High Similarity NPC472455
0.9416 High Similarity NPC78492
0.9412 High Similarity NPC170492
0.9412 High Similarity NPC298692
0.9412 High Similarity NPC248793
0.9412 High Similarity NPC180301
0.9412 High Similarity NPC469405
0.9408 High Similarity NPC244577
0.9408 High Similarity NPC474021
0.9408 High Similarity NPC477897
0.9408 High Similarity NPC289774
0.9408 High Similarity NPC471677
0.9408 High Similarity NPC474023
0.9408 High Similarity NPC263384
0.9408 High Similarity NPC471676
0.9408 High Similarity NPC209846
0.9408 High Similarity NPC472422
0.9408 High Similarity NPC472420
0.9408 High Similarity NPC328740
0.9371 High Similarity NPC474024
0.9371 High Similarity NPC477154
0.9371 High Similarity NPC117854
0.9371 High Similarity NPC6588
0.9367 High Similarity NPC300053
0.9367 High Similarity NPC108433
0.9367 High Similarity NPC239752
0.9367 High Similarity NPC275780
0.9367 High Similarity NPC472450
0.9367 High Similarity NPC50960
0.9363 High Similarity NPC229632
0.9363 High Similarity NPC201800
0.9363 High Similarity NPC261470
0.9363 High Similarity NPC194427
0.9363 High Similarity NPC472964
0.9359 High Similarity NPC471976
0.9359 High Similarity NPC472902
0.9359 High Similarity NPC474960
0.9359 High Similarity NPC321399
0.9359 High Similarity NPC101731
0.9359 High Similarity NPC470183
0.9359 High Similarity NPC471973
0.9359 High Similarity NPC476980
0.9359 High Similarity NPC299436
0.9355 High Similarity NPC475267
0.9355 High Similarity NPC471479
0.9355 High Similarity NPC48208
0.9355 High Similarity NPC52530
0.9355 High Similarity NPC471515
0.9355 High Similarity NPC470402
0.9355 High Similarity NPC476981
0.9355 High Similarity NPC474836
0.9355 High Similarity NPC156057
0.9355 High Similarity NPC474208
0.9355 High Similarity NPC162869
0.9355 High Similarity NPC67876
0.9355 High Similarity NPC78225
0.9351 High Similarity NPC37392
0.9351 High Similarity NPC256925
0.9351 High Similarity NPC117992
0.9351 High Similarity NPC168247
0.9351 High Similarity NPC304745
0.9351 High Similarity NPC200246
0.9351 High Similarity NPC111341
0.9351 High Similarity NPC472280
0.9351 High Similarity NPC470681
0.9351 High Similarity NPC152951
0.9351 High Similarity NPC477958
0.9351 High Similarity NPC57674

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475784 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9539 High Similarity NPD2393 Clinical (unspecified phase)
0.9474 High Similarity NPD1934 Approved
0.9245 High Similarity NPD6166 Phase 2
0.9245 High Similarity NPD6168 Clinical (unspecified phase)
0.9245 High Similarity NPD6167 Clinical (unspecified phase)
0.9216 High Similarity NPD4380 Phase 2
0.9161 High Similarity NPD2801 Approved
0.9074 High Similarity NPD7054 Approved
0.9018 High Similarity NPD7074 Phase 3
0.9018 High Similarity NPD7472 Approved
0.8947 High Similarity NPD1511 Approved
0.8896 High Similarity NPD3818 Discontinued
0.8889 High Similarity NPD4378 Clinical (unspecified phase)
0.8875 High Similarity NPD5494 Approved
0.8868 High Similarity NPD4381 Clinical (unspecified phase)
0.8861 High Similarity NPD3817 Phase 2
0.8855 High Similarity NPD7808 Phase 3
0.8848 High Similarity NPD6797 Phase 2
0.8831 High Similarity NPD1512 Approved
0.8805 High Similarity NPD3882 Suspended
0.8795 High Similarity NPD7251 Discontinued
0.875 High Similarity NPD7075 Discontinued
0.8743 High Similarity NPD4338 Clinical (unspecified phase)
0.8727 High Similarity NPD7804 Clinical (unspecified phase)
0.8688 High Similarity NPD4868 Clinical (unspecified phase)
0.8679 High Similarity NPD7096 Clinical (unspecified phase)
0.8675 High Similarity NPD1552 Clinical (unspecified phase)
0.8675 High Similarity NPD1550 Clinical (unspecified phase)
0.8645 High Similarity NPD7410 Clinical (unspecified phase)
0.8625 High Similarity NPD8443 Clinical (unspecified phase)
0.8618 High Similarity NPD1549 Phase 2
0.8616 High Similarity NPD6801 Discontinued
0.8614 High Similarity NPD5844 Phase 1
0.8487 Intermediate Similarity NPD2796 Approved
0.8476 Intermediate Similarity NPD6959 Discontinued
0.8447 Intermediate Similarity NPD7819 Suspended
0.8438 Intermediate Similarity NPD7411 Suspended
0.8424 Intermediate Similarity NPD6232 Discontinued
0.8421 Intermediate Similarity NPD1510 Phase 2
0.8383 Intermediate Similarity NPD7473 Discontinued
0.8353 Intermediate Similarity NPD6559 Discontinued
0.8294 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8282 Intermediate Similarity NPD5402 Approved
0.8228 Intermediate Similarity NPD6799 Approved
0.8187 Intermediate Similarity NPD5403 Approved
0.8158 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8158 Intermediate Similarity NPD1240 Approved
0.8158 Intermediate Similarity NPD1613 Approved
0.8144 Intermediate Similarity NPD1247 Approved
0.8133 Intermediate Similarity NPD919 Approved
0.811 Intermediate Similarity NPD1465 Phase 2
0.8107 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8063 Intermediate Similarity NPD5401 Approved
0.8052 Intermediate Similarity NPD1607 Approved
0.8037 Intermediate Similarity NPD6599 Discontinued
0.8012 Intermediate Similarity NPD7768 Phase 2
0.7961 Intermediate Similarity NPD3027 Phase 3
0.7925 Intermediate Similarity NPD3750 Approved
0.7922 Intermediate Similarity NPD943 Approved
0.7911 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD2935 Discontinued
0.7895 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD2800 Approved
0.7862 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD3749 Approved
0.784 Intermediate Similarity NPD2533 Approved
0.784 Intermediate Similarity NPD2532 Approved
0.784 Intermediate Similarity NPD2534 Approved
0.7836 Intermediate Similarity NPD3926 Phase 2
0.7833 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD4628 Phase 3
0.7803 Intermediate Similarity NPD3751 Discontinued
0.7784 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD3787 Discontinued
0.7747 Intermediate Similarity NPD4363 Phase 3
0.7747 Intermediate Similarity NPD4360 Phase 2
0.7744 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD920 Approved
0.773 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD7199 Phase 2
0.7697 Intermediate Similarity NPD1653 Approved
0.7677 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD1551 Phase 2
0.7673 Intermediate Similarity NPD6100 Approved
0.7673 Intermediate Similarity NPD6099 Approved
0.7672 Intermediate Similarity NPD7584 Approved
0.7663 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD447 Suspended
0.7643 Intermediate Similarity NPD5124 Phase 1
0.7643 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD230 Phase 1
0.764 Intermediate Similarity NPD8312 Approved
0.764 Intermediate Similarity NPD8313 Approved
0.764 Intermediate Similarity NPD1243 Approved
0.7627 Intermediate Similarity NPD7685 Pre-registration
0.7622 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD37 Approved
0.761 Intermediate Similarity NPD3748 Approved
0.761 Intermediate Similarity NPD7033 Discontinued
0.7607 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD6234 Discontinued
0.76 Intermediate Similarity NPD7228 Approved
0.7595 Intermediate Similarity NPD6651 Approved
0.7593 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7588 Intermediate Similarity NPD4965 Approved
0.7588 Intermediate Similarity NPD4966 Approved
0.7588 Intermediate Similarity NPD4967 Phase 2
0.7571 Intermediate Similarity NPD5953 Discontinued
0.7564 Intermediate Similarity NPD2313 Discontinued
0.7561 Intermediate Similarity NPD7390 Discontinued
0.7561 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7557 Intermediate Similarity NPD7286 Phase 2
0.7548 Intermediate Similarity NPD4908 Phase 1
0.7546 Intermediate Similarity NPD6190 Approved
0.7545 Intermediate Similarity NPD3226 Approved
0.754 Intermediate Similarity NPD6782 Approved
0.754 Intermediate Similarity NPD6777 Approved
0.754 Intermediate Similarity NPD6780 Approved
0.754 Intermediate Similarity NPD6781 Approved
0.754 Intermediate Similarity NPD6776 Approved
0.754 Intermediate Similarity NPD6779 Approved
0.754 Intermediate Similarity NPD6778 Approved
0.7532 Intermediate Similarity NPD1933 Approved
0.7529 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD2346 Discontinued
0.7515 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD8150 Discontinued
0.75 Intermediate Similarity NPD2799 Discontinued
0.75 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD2424 Discontinued
0.744 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7434 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD7435 Discontinued
0.7418 Intermediate Similarity NPD8434 Phase 2
0.7412 Intermediate Similarity NPD6844 Discontinued
0.7409 Intermediate Similarity NPD8151 Discontinued
0.7407 Intermediate Similarity NPD2344 Approved
0.7391 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD4625 Phase 3
0.7372 Intermediate Similarity NPD9494 Approved
0.7371 Intermediate Similarity NPD5710 Approved
0.7371 Intermediate Similarity NPD5711 Approved
0.7368 Intermediate Similarity NPD8455 Phase 2
0.7353 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7783 Phase 2
0.733 Intermediate Similarity NPD7698 Approved
0.733 Intermediate Similarity NPD7696 Phase 3
0.733 Intermediate Similarity NPD7697 Approved
0.7326 Intermediate Similarity NPD4361 Phase 2
0.7326 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD1610 Phase 2
0.7317 Intermediate Similarity NPD1652 Phase 2
0.7305 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD7871 Phase 2
0.7292 Intermediate Similarity NPD7870 Phase 2
0.7285 Intermediate Similarity NPD1548 Phase 1
0.7278 Intermediate Similarity NPD3823 Discontinued
0.7277 Intermediate Similarity NPD6823 Phase 2
0.7273 Intermediate Similarity NPD6535 Approved
0.7273 Intermediate Similarity NPD6534 Approved
0.7268 Intermediate Similarity NPD7701 Phase 2
0.7268 Intermediate Similarity NPD7585 Approved
0.7244 Intermediate Similarity NPD1203 Approved
0.7238 Intermediate Similarity NPD7240 Approved
0.7235 Intermediate Similarity NPD7458 Discontinued
0.7233 Intermediate Similarity NPD3268 Approved
0.7233 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD6798 Discontinued
0.7232 Intermediate Similarity NPD5242 Approved
0.7229 Intermediate Similarity NPD2309 Approved
0.7225 Intermediate Similarity NPD5353 Approved
0.7216 Intermediate Similarity NPD8127 Discontinued
0.7216 Intermediate Similarity NPD7583 Approved
0.7215 Intermediate Similarity NPD6832 Phase 2
0.7212 Intermediate Similarity NPD6674 Discontinued
0.7212 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD7549 Discontinued
0.7197 Intermediate Similarity NPD2798 Approved
0.7195 Intermediate Similarity NPD7266 Discontinued
0.7194 Intermediate Similarity NPD7874 Approved
0.7194 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD4308 Phase 3
0.7175 Intermediate Similarity NPD7229 Phase 3
0.7158 Intermediate Similarity NPD7699 Phase 2
0.7158 Intermediate Similarity NPD7700 Phase 2
0.7157 Intermediate Similarity NPD7801 Approved
0.7152 Intermediate Similarity NPD2861 Phase 2
0.7143 Intermediate Similarity NPD4060 Phase 1
0.7134 Intermediate Similarity NPD2797 Approved
0.7115 Intermediate Similarity NPD4749 Approved
0.7101 Intermediate Similarity NPD4662 Approved
0.7101 Intermediate Similarity NPD4661 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data